RALEIGH, N.C. (WNCN) – On Friday, the FDA will discuss Pfizer’s request for authorization for its booster. In documents posted online, the FDA took note of conflicting data concerning boosters. The ...
SAN FRANCISCO -- As more people are eligible to get vaccinated, reports of side effects after the second Pfizer and Moderna shots are surfacing. Dr. Robert Wachter, chief of medicine at UCSF says many ...
A new study shows side effects of the Pfizer vaccine are less than trials predicted, encouraging news for those hesitant to get their shots for fear of adverse reaction. A report from Lancet ...
As the vaccination campaign against COVID-19 continues and more people receive their second dose, many have reported that it caused more intense side effects than after the first. But vaccine experts ...
The US Food and Drug Administration has issued emergency use authorization (EUA) for the Covid-19 vaccine developed by Pfizer and BioNTech. After months of development, emergency use was authorized ...
Weight loss with Ozempic or Wegovy requires patients to inject themselves with the medication — a reported drawback for some people. That's why Pfizer and other drug manufacturers are racing for ...
Pfizer announced Friday that it is discontinuing development of its twice-daily weight loss pill danuglipron after a clinical trial showed "high rates" of adverse side effects among users. The ...
Pfizer was seen as one of the best COVID-19 vaccines. However, a new study received so far only by a few, points to the actual vaccine being unclean, untested, and possibly dangerous with enormous ...
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost significant weight but had trouble tolerating the ...
A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...
As the race for the coronavirus vaccine continues, those in the trials for both Moderna and Pfizer are describing the side effects. "I'm Jennifer Haller and I'm the first person in the U.S. to trial ...